Innovative research and development of Zhongyan Xueyabao — A series of new products for the treatment of high and low blood pressure diseases

Abstract

Objective: Regarding the reality of isolated and static program treating hypertension into “the life-long diseases”, to put forward the important pharmaceutics topic of innovation and development of series products for the treatment of high and low blood pressure diseases — Zhongyan Xueyabao based on the 10 years' practice on the treatment of blood pressure diseases. Methods: The fundamental cause and pathogenesis of hypertension and hypotension are the pathological changes of regulation and control system of blood pressure. By using the methods of conditioning, controlling and expansion, the well-developed Zhongyan Xueyabao enhances the control system of blood pressure, nurse the regulation and control function of blood pressure back to the health condition, cure part of hypertension and hypotension diseases and give them a radical cure such as the indication, budding, beginning and mildness of these diseases. Results: That is the objective reflect of the law of the unity of opposites in blood pressure diseases. The new road of the dialectical thinking of hypertension and hypotension is opened up. Zhongyan Xueyabao has eight ordinary types and eight enhanced ones. The effect of these types multiplied with the aura of The Book of Changes. The cure rate is about 70–80%. Conclusion: The braveness should be enough to declare the war against blood pressure diseases and win it. The traditional Chinese medicine is magical, valuable and advantageous. They will win the glory of traditional Chinese medicine, live up to expectation for Chinese people and make great contributions to the eradication of the disease disasters for the world's people. The excellent talents in Chinese medicine sectors should unite and rewrite the history track of hypertension, so as to fill the blank of the radical cure of hypertension and hypotension, at the same time, lead the people out of the “scam” of “life-long illness” and the “dead end” of a variety of “critical complications”, and open up a new road of prevention and treatment of blood pressure diseases.